Search
-
[WEBINAR] Sustainability: What we know and how you can act
Consumer expectations on sustainability are rising, but in fact, it’s complex and sometimes not easy for our clients to not only committed to sustainability but also implement incremental steps towards becoming truly sustainable.
-
Uncover the power of the patient voice: Healthcare-focused Social Intelligence & Text Analytics
The rich wealth of unstructured and unrequested data on social media offers critical input to your brand’s story. Ipsos’ healthcare-focused Social Intelligence & Text Analytics offering, powered by Synthesio’s leading technology, unlocks the opportunities within unstructured data, bringing you unparalleled insights into authentic patient experiences and perceptions.
-
[EVENT] CX Council – Structuring the Unstructured
On 20 November, the CX Council reconvenes to discuss one if the hottest topics in the industry, unstructured feedback.
-
Artificial intelligence: Four points of vigilance
This article on AI from Helen Zeitoun, CEO Science Organisation and CEO Ipsos in France, was originally published in French in Strategies, March 2019.
-
What keeps communicators awake at night?
Reputation Council members across the world face a range of business challenges – but what are the biggest issues that keep them awake at night?
-
Ipsos Update - May 2018
May’s edition includes new papers on viewability and modern partisanship, as well as global studies on ‘natural’ food, self-driving cars and societal divides.
-
Understanding Society: Beyond Populism
Download the latest edition of Understanding Society - Beyond Populism – which explores the major political and social shifts around the world.
-
Ipsos Update - March 2017
Welcome to the March edition of Ipsos Update – our monthly selection of research and thinking from Ipsos teams around the world.
-
Brexit and the UK Pharma Industry
The ‘In’ and ‘Out’ campaigns are now intensifying, but ‘Brexit’ has been a constant topic of conversation since the referendum date was announced 3 months ago. A British exit could have widespread repercussions for many sectors within the UK economy, especially in highly regulated and controlled industries such as pharmaceuticals.